OptimizeRx completes acquisition of Medicx Health; FY2022 revenue $28.1M

OptimizeRx Corp

Medicx FY2022: revenue $28.1M, net income $4.5M; FY2021: revenue $18.5M, net income $0.8M.
Deal closed Oct 24, 2023; this amendment provides audited and pro forma financials.
Medicx balance sheet Dec 2022: total assets $18.6M, stockholders' equity $12.4M.
Pro forma combined balance sheet at June 30, 2023 and statements of ops included.
Medicx revenue grew 51% YoY from 2021 to 2022; net income increased 5.8x.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.